Interventional Radionuclide Therapy of Hepatocellular Carcinoma: Assessment of Intratumoral Retention of HPMA Copolymers
To develop new radiopharmaceuticals for the interventional radionuclide therapy of recurrent hepatocellular carcinoma, poly(HPMA)-APMA-DTPA[HPMA=N-(2-hydroxypropyl) methacrylamide; APMA=N-(3-aminopropyl)methacrylamide; DTPA=diethylenetriaminepentaacetic acidl was synthesized by free radical precipit...
Saved in:
Published in | Chemical research in Chinese universities Vol. 29; no. 1; pp. 183 - 188 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Heidelberg
Jilin University and The Editorial Department of Chemical Research in Chinese Universities
01.02.2013
Key Laboratory of Eco-environment-related Polymer Materials, Ministry of Education, Key Laboratory of Polymer Materials of Gansu Province, College of Chemistry and Chemical Engineering,Northwest Normal University, Lanzhou 730070, P.R.China%Department of Nuclear Medicine, Gansu Academy of Medical Sciences & Gansu Provincial Tumor Hospital, Lanzhou 730050, P.R.China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To develop new radiopharmaceuticals for the interventional radionuclide therapy of recurrent hepatocellular carcinoma, poly(HPMA)-APMA-DTPA[HPMA=N-(2-hydroxypropyl) methacrylamide; APMA=N-(3-aminopropyl)methacrylamide; DTPA=diethylenetriaminepentaacetic acidl was synthesized by free radical precipitation polymerization in acetone/dimethylsulfoxide with N,N'-azobis(isobutyronitrile) as the initiator. The copolymers were characterized with nuclear magnetic resonance(NMR) spectroscopy and gel permeation chromatography(GPC, Mn=2.2xl04, Mw/Mn=l.38). Subsequently, poly(HPMA)-APMA-DTPA was conjugated with 99mTC radionuclide. Prolonged retention of poly(HPMA)-APMA-DTPA conjugate within the tumor tissues was demonstrated by single-photon emission computed tomography computed tomography(SPECT-CT) at 1, 2, 4 and 24 h following intra-tumoral injection of the conjugate to hepatocellular carcinoma xenografts in mice. DTPA-99mTc was also synthesized and characterized for comparison. The data suggest that the poly(HPMA)-APMA-DTPA conjugates might be useful for the interventional radionuclide therapy of recurrent hepatocellular carcinoma in humans. |
---|---|
Bibliography: | Hepatocellular carcinoma; Interventional radionuclide therapy; HPMA copolymer; Radiotracer 22-1183/06 To develop new radiopharmaceuticals for the interventional radionuclide therapy of recurrent hepatocellular carcinoma, poly(HPMA)-APMA-DTPA[HPMA=N-(2-hydroxypropyl) methacrylamide; APMA=N-(3-aminopropyl)methacrylamide; DTPA=diethylenetriaminepentaacetic acidl was synthesized by free radical precipitation polymerization in acetone/dimethylsulfoxide with N,N'-azobis(isobutyronitrile) as the initiator. The copolymers were characterized with nuclear magnetic resonance(NMR) spectroscopy and gel permeation chromatography(GPC, Mn=2.2xl04, Mw/Mn=l.38). Subsequently, poly(HPMA)-APMA-DTPA was conjugated with 99mTC radionuclide. Prolonged retention of poly(HPMA)-APMA-DTPA conjugate within the tumor tissues was demonstrated by single-photon emission computed tomography computed tomography(SPECT-CT) at 1, 2, 4 and 24 h following intra-tumoral injection of the conjugate to hepatocellular carcinoma xenografts in mice. DTPA-99mTc was also synthesized and characterized for comparison. The data suggest that the poly(HPMA)-APMA-DTPA conjugates might be useful for the interventional radionuclide therapy of recurrent hepatocellular carcinoma in humans. |
ISSN: | 1005-9040 2210-3171 |
DOI: | 10.1007/s40242-013-2089-8 |